Antoine Pharma
Timeline
14 events since 2019Board
Filings
Financial
2020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed PDFfull format · 63 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0732705039
Annual accounts 2024 filed PDFfull format · 42 days before the deadline
2024
Annual accounts 2023 filed PDFfull format · 36 days before the deadline
2023
Highest result from 2019 to 2025 net €118,130 ▲3.5% The operating result of €161,755 and the net result of €118,130 are both a record.
Annual accounts 2022 filed PDFfull format · 61 days before the deadline
2022
Equity above €200,000 equity €273,424 ▲71.7% With a profit in every financial year since 2019, equity grows to €273,424.
appointed as co administratriceGeneral meeting of 25-04-20222 points ▸
- General meeting of 25-04-2022
- appointed as co administratrice
Annual accounts 2021 filed PDFfull format · 52 days before the deadline
2021
Equity above €150,000 equity €159,263 ▲127% With a profit in every financial year since 2019, equity grows to €159,263.
Annual accounts 2020 filed PDFfull format · 66 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 65 days before the deadline
2019
acts as permanent representative1 point ▸
- acts as permanent representative
- The deed holds 1 more point.
IncorporationFounding capital of €50,000, 100 shares · Founded by · appointed as director · published on 22-08-20195 points ▸
- Founded by
- The founding capital is €50,000, divided into 100 shares
- holds all the shares
- The registered office is at Place Fernand Cocq 26, 1050 Ixelles
- appointed as director, not named in the articles
- The deed holds 15 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank